Blood urea nitrogen diagnostic market: Asia Pacific will have a significant share of the global market

zA

Key Drivers of Global Blood Urea Nitrogen Diagnostics Market Request Brochure of Blood Urea Nitrogen Diagnostics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75171

Various scientific studies and publications suggest that kidney diseases are uncommon among people aged 45 years or below. Developments in the medical field have led to increase in the life expectancy of people, which implies that more number of people are exceeding the average age of 50 years. According to the United Nations, the number of people aged 60 years or above is likely to increase from 841 million in 2013 to over 2 billion by 2050. Changing demographics and rising geriatric population are shifting a substantial number of people to the higher illness category, which requires continuous medical intervention. Rise in the global geriatric population and changing lifestyle are the most common risk factors for the development of kidney diseases. The number of elderly people diagnosed with renal diseases is increasing drastically in developed as well as developing economies. This factor is expected to drive the global blood urea nitrogen diagnostics market in the near future.
Moreover, recently i.e. in 2018, Siemens Healthineers received the FDA approval for its blood urea nitrogen point-of-care tests. Such advancements in the measurement of blood urea nitrogen are likely to drive the global blood urea nitrogen diagnostics market during the forecast period.
Purchase the Blood Urea Nitrogen Diagnostics Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=75171&ltype=S

Focusing on emerging markets presents an opportunity for major players operating in the global blood urea nitrogen diagnostics, as the number of patients with renal diseases is rising across the world. According to a survey conducted by the Economist Intelligence Unit Limited, countries in Asia Pacific such as India and China are focusing on improving primary health care facilities and the overall health care spending of these countries is estimated to increase at an average rate of 17% and 14% annually from 2015 to 2019.
Asia Pacific to Hold a Major Share of Global Blood Urea Nitrogen Diagnostics Market

Market Opportunities Request for Analysis of COVID-19 Impact on Blood Urea Nitrogen Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75171

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75171
Asia Pacific is likely to dominate the global blood urea nitrogen diagnostics market in the next few years, due to rise in the prevalence of kidney diseases and the large number of elderly people suffering from kidney diseases in the region. According to a report published by the India Today magazine in March 2019, around 100,000 patients are diagnosed with end-stage kidney disease (ESKD) in India every year.

Siemens Healthineers
Thermo Fisher Scientific
F. Hoffmann-La Roche AG
Danaher Corporation
StressMarq Biosciences Inc.
Arbor Assays
Abbott
PerkinElmer, Inc.
Major players operating in the global blood urea nitrogen diagnostics market are: Key Players Operating in Global Market

News Highlights Games

  • Headline: Blood urea nitrogen diagnostic market: Asia Pacific will have a significant share of the global market
  • Check all news and articles from the Gaming news updates.
Disclaimer: If you need to update/edit/remove this news or article then please contact our support team.
For Latest Updates Follow us on Google News
Bollyinside - US Local News & Breaking News Stories
Logo
Compare items
  • Total (0)
Compare
0